Xcout IntelHBM Healthcare Investments AG competitors & alternatives
The 12 closest competitors and alternatives to HBM Healthcare Investments AG among asset management companies — ranked by similarity to what HBM Healthcare Investments AG actually does, not by market-cap band.
Subscribe to see HBM Healthcare Investments AG’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About HBM Healthcare Investments AG
HBM Healthcare Investments AG strategically deploys capital through both direct investments and allocations to other funds, targeting middle-market and mature companies. Its investment mandate is broad, encompassing various stages from nascent startups, early-stage, mid-stage, and late-stage private ventures to emerging unlisted businesses, smaller public companies, management buyouts, growth capital opportunities, and private investments in public equities (PIPEs). Within its fund-of-funds segment, it specifically backs venture capital funds. The firm also provides financing for the spin-off of product lines or departments from larger corporations, supports the expansion or restructuring of established businesses, and participates in seed, venture, and expansion capital rounds, along with additional buyout transactions. HBM's primary focus is on private and public entities within the healthcare sector, with a strong emphasis on human medicine, pharmaceuticals (including biopharma), biotechnology, diagnostics, medical technology, and related industries. Initial investments are typically made in companies whose core products are either in clinical development or the stage immediately preceding it. The fund adopts a global investment approach, concentrating its efforts particularly on the Asia Pacific region, North America, and Europe. For publicly listed companies, HBM generally targets those that have transitioned from its private investment portfolio. The firm often increases its stake in portfolio companies by participating in subsequent financing rounds or after the company's initial public offering. HBM may acquire controlling interests in portfolio companies and frequently secures a seat on their Board of Directors. While equity investments are its predominant method, it also utilizes a range of other financial instruments, including convertible bonds, debt securities, structured products, and derivatives. HBM's primary exit strategies for its portfolio companies involve trade sales or initial public offerings.
HBM Healthcare Investments AG at a glance
HBM Healthcare Investments AG is an asset management company headquartered in Zug, Switzerland. It is publicly listed (0QOC) with a market capitalisation of $2B. Xcout tracks 6 named people at HBM Healthcare Investments AG, including Dr. Andreas Wicki (Dr Andreas Wicki).
HBM Healthcare Investments AG leadership
- Dr. Andreas WickiDr Andreas Wicki
- Hans Peter HaslerChairman of the Board of Directors
- Dr Elaine V. JonesBoard Member
- Dr Rudolf LanzBoard Member
- Dr Stella X. XuBoard Member
- Mario G. GiulianiBoard Member
Top 12 HBM Healthcare Investments AG competitors
Ranked by semantic similarity — how close each company is to HBM Healthcare Investments AG by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar asset management company
HBM Partners is a Swiss healthcare asset manager and investor that provides venture, growth, and buy-out financing to private and public companies in the biopharma, medtech, diagnostics, and healthcare sectors. The firm advises specialized equity investment funds and supports entrepreneurial companies by providing capital and strategic industry expertise.
Similar asset management company
Private Equity Holding AG implements a comprehensive investment strategy, primarily through fund-of-funds, secondary indirect investments, and carefully selected direct co-investments. Its fund-of-funds approach spans various categories, including venture, buyout, special situation, secondary, and balanced funds, with a specific exclusion of very early-stage venture capital and mega-buyout funds. Within its venture fund allocations, a strong emphasis is placed on technology sectors such as Internet, telecommunications, information technology, life sciences, and other high-tech areas like semiconductors and electronics. For direct participation, the company typically opts to co-invest alongside partner funds or offer pre-IPO financing in the form of convertible loans. Its investment scope is wide-ranging, encompassing businesses at diverse stages and scenarios, from mid-to-late venture, middle-market, and developmental phases, to management buyouts and buy-ins, succession issues, bridge financings, spin-offs, distressed and turnaround situations, and mature companies. It also considers Private Investment in Public Equity (PIPES). Geographically, Private Equity Holding AG focuses on developed European markets, with particular attention to Switzerland, Germany, France, and the United Kingdom, alongside Central and Eastern Europe, Israel, and the United States. For expansion or development capital, it targets companies generating annual revenues exceeding $1 million. The firm channels most of its investments through offshore entities and generally aims to secure a controlling interest.
Similar asset management company
Castle Private Equity AG operates as an evergreen investment vehicle. Its strategy involves both allocating capital to other private equity funds (fund of funds) and making direct equity investments. The firm targets a broad spectrum of private equity strategies, encompassing large, late-stage, small, and mid-market buyouts, as well as growth capital, distressed debt, and mezzanine financing opportunities. A smaller segment of its portfolio is allocated to direct participations in private companies, covering early and late-stage venture capital, and Special Situations. Investment structures include commitments to newly formed funds and acquiring existing fund interests in the secondary market, with secondary investing being a core component of its approach. The company seeks prospects across manufacturing, biotechnology, life sciences, retail, distribution, media, telecommunications, and information technology sectors. While maintaining a global investment scope, its primary geographical emphasis is on the developed private equity markets of Europe and North America. Castle Private Equity AG typically aims for majority ownership stakes, securing two board representatives, and generally holds investments for a period of ten years.
Similar asset management company
HgCapital Trust plc (2017) strategically allocates capital to a diverse range of opportunities, encompassing direct investments in both publicly traded and privately held companies, as well as participations in fund-of-funds arrangements. The trust permits its entire gross asset base (100%) to be exposed to unlisted investments. However, it imposes a strict limit, ensuring that no individual direct or indirect investment in an unlisted company or closed-ended fund exceeds 15% of its gross assets. The primary focus for its direct investments lies in middle-market buyouts across the Technology, TMT, Services, and Industrials Technology sectors, targeting businesses with enterprise values between £80 million (approximately $97.43 million) and £500 million (approximately $608.95 million). It also seeks lower mid-market buyout prospects specifically within the TMT sector, focusing on companies valued from £20 million (approximately $24.35 million) to £80 million (approximately $97.43 million). Beyond these, the fund explores direct investments in hospitality (hotels, restaurants, leisure), consumer durables and apparel, various service industries, and renewable energy. Geographically, HgCapital Trust prioritizes investments within Europe, with a distinct emphasis on Northern Europe, including the United Kingdom, Germany, France, the Benelux region, and the Nordics, alongside other European territories. The trust typically commits between £100 million (approximately $202.89 million) and £500 million (approximately $1014.45 million) to each of its portfolio companies. For its fund-of-funds segment, it specifically invests in limited partnership vehicles overseen by HgCapital. A cornerstone of its investment philosophy is to secure a majority ownership stake in the businesses it supports.
Similar asset management company
Hamilton Lane Incorporated operates as an investment management firm, specializing in both direct investments and fund-of-funds strategies. The firm offers a comprehensive range of services, including: Tailored Separate Accounts: Structured as single-client vehicles, these are customized to meet specific client requirements. Specialized Investment Strategies: This category encompasses offerings such as fund-of-funds, secondary market transactions, co-investments, Taft-Hartley plans, and distribution management. Advisory Services: Hamilton Lane provides expert guidance, covering thorough due diligence, strategic portfolio planning, continuous monitoring, and performance reporting. Reporting and Analytics: The company also delivers advanced solutions for data reporting and analysis. For its direct investments, Hamilton Lane targets a diverse array of companies, participating across various stages of their lifecycle. This includes early, mid, and late-stage venture capital, mature businesses, and growth equity opportunities. The firm's interests also extend to emerging growth companies, distressed debt scenarios, later-stage financing, corporate turnarounds, bridge financing, mezzanine capital, and leveraged buyouts, primarily within the middle market segment. When pursuing a fund-of-funds approach, Hamilton Lane allocates capital to a variety of specialized funds. These include those focused on mezzanine, venture capital, private equity, turnaround, secondary investments, real estate, and special situations. Beyond specific asset classes, the firm's investment scope spans multiple sectors, including real estate, technology, healthcare, education, natural resources, energy, essential consumer goods, cleantech, environmental initiatives, community development, and financial empowerment projects. Geographically, Hamilton Lane's private equity investments demonstrate a wide global footprint, with its presence extending across North America (including the United States), Latin America, Western Europe (including the United Kingdom), the Middle East, Africa, Asia (including Japan), and Australia. The firm typically aims to commit between $1 million and $100 million per company, often prioritizing the acquisition of a majority ownership stake in its portfolio companies. Established in 1991, Hamilton Lane Incorporated maintains its headquarters in Conshohocken, Pennsylvania, complemented by a network of additional offices across Europe, North America, and Asia.
Similar asset management company
Altamir SCA, formerly known as Altamir Amboise, operates as a private equity firm that engages in both direct equity investments and fund-of-fund strategies, primarily targeting small and medium-sized companies. For its direct investment activities, the firm focuses on middle-market opportunities, encompassing buyout and growth capital financing. A particular area of interest is the acquisition of underdeveloped divisions within larger corporations. When investing in other funds, Altamir gravitates towards private equity vehicles dedicated to growth capital and leveraged buyout transactions. The firm's sectorial interests are diverse, spanning healthcare, technology, media, and telecommunications (TMT), digital enterprises, various service industries, and retail and distribution. Within healthcare, it specifically seeks high-growth potential in areas such as health services (e.g., hospitalization, home care, medical analysis), medical devices, niche pharmaceutical laboratories, and related sectors like dermo-cosmetics, galenic development, and data/service providers for health organizations. Broader retail, consumer, business, and financial services also fall within its purview. Geographically, Altamir seeks unlisted companies primarily across Europe, including Belgium, France, Luxembourg, Switzerland, Monaco, Italy, the Netherlands, Germany, and French-speaking Europe, alongside the United States, Canada, and key emerging markets like China, India, and Brazil. For small and mid-cap companies, its preference lies in Continental Europe, with a strong focus on France, Italy, and the Benelux region. For larger enterprises, its investment reach extends to Europe, North America, and emerging economies such as China, India, and Brazil. Altamir typically targets small and mid-cap companies with an enterprise value ranging from €50 million ($55.36 million) to €500 million ($553.6 million). For larger companies, the enterprise value for investment falls between €500 million ($553.60 million) and €3,000 million ($3,321.62 million). When investing in funds, the firm aims for a majority ownership stake or a leading shareholder position. Altamir aligns its investment and divestment processes with the private equity funds of Apax Partners France and Amboise Investissement under identical conditions, and also directly invests in funds managed or advised by Apax Partners France and Apax Partners LLC. The firm's objective is to exit its investments within a five-year timeframe, and all capital deployment is made from its own balance sheet. Altamir SCA was established in 1995 and is based in Paris, France.
Similar asset management company
Teuza - A Fairchild Technology Venture Ltd. primarily focuses on providing growth equity and hybrid debt-equity financing solutions. Its investment mandate spans a wide range of company maturities, from nascent seed and startup phases through early, mid, and late-stage ventures, extending to established middle-market enterprises. The firm actively seeks opportunities across various technology-driven sectors, including semiconductors, enterprise software, general IT software, healthcare, electronics, medical devices, biotechnology, and both telecommunications and broader communications industries. Geographically, Teuza prioritizes investments in companies located in Israel, China, Canada, and the United States. Individual investments typically fall within the range of $1 million to $2 million. Furthermore, Teuza generally acquires an equity stake ranging from 25% to 49% in its portfolio firms, often securing a seat on their Board of Directors. The firm's strategy for exiting these investments primarily involves either an Initial Public Offering (IPO) or a Merger and Acquisition (M&A) deal.
Similar asset management company
Draper Esprit VCT plc operates as a venture capital trust and fund manager, focusing primarily on direct investments. The firm's investment strategy covers all venture stages, including early, mid, and late-stage opportunities, with a particular emphasis on growth capital. It allocates capital to businesses predominantly in the healthcare, software, and services sectors, with its geographical investment scope limited to the United Kingdom.
Similar asset management company
JZ Capital Partners Limited is an investment firm focused on middle-market companies across North America and Europe. Its diverse investment strategies encompass micro-cap buyouts, mid-stage venture capital, and broader equity opportunities. The firm also engages in various credit investments, including distressed debt, structured financings, and high-yield securities. Additionally, it provides different forms of debt, such as senior secured debt (including first and second lien bank loans), and mezzanine loans, alongside other mezzanine financing options. JZ Capital Partners also acquires publicly traded securities within the middle-market segment. The fund targets businesses in a range of sectors, including real estate, consumer goods, healthcare, chemicals, and industrial industries.
Similar asset management company
JPEL Private Equity Limited operates as an investment vehicle concentrating on three distinct strategies: direct equity stakes, secondary direct acquisitions, and allocations to other funds. Its primary capital deployment targets include buyout, venture capital, and special situations funds. The firm maintains a global investment mandate, although it particularly emphasizes opportunities across Europe, North America, and Asia. For its direct investment activities, JPEL frequently seeks to co-invest in collaboration with other private equity sponsors.
Similar asset management company
Hercules Capital, Inc. is a business development company. The firm specializing in providing private equity, venture debt, and growth capital to privately held venture capital-backed companies at all stages of development from mid venture to expansion stage including select publicly listed companies and select special opportunity companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, SaaS Finance, energy technology, sustainable and renewable technology, and life sciences. Within technology the firm focuses on advanced specialty materials and chemicals; communication and networking, consumer and business products; consumer products and services, digital media and consumer internet; electronics and computer hardware; enterprise software and services; gaming; healthcare services; information services; business services; media, content and information; mobile; resource management; security software; semiconductors; semiconductors and hardware; and software sector. Within energy technology, it invests in agriculture; clean technology; energy and renewable technology, fuels, and power technology; geothermal; smart grid and energy efficiency and monitoring technologies; solar; and wind. Within life sciences, the firm invests in biopharmaceuticals; biotechnology tools; diagnostics; drug discovery, drug platform, development, and delivery; medical devices and equipment; surgical devices; therapeutics; pharma services; and specialty pharmaceuticals. Within sustainable and renewables, it invests in Vehicle Technology, Energy Generation and Storage, Ag Technology, Advanced Materials, and Industry 4.0. It also invests in educational services. The firm invests primarily in United States based companies and considers investment in the West Coast, Mid-Atlantic regions, Southeast and Midwest, particularly in the areas of software, biotech, and information services. The firm prefers to invest between $5 million and $500 million in equity per transactions. It invests in debt between $1 million and $40 million in companies focused primarily on business services, communications, electronics, hardware, and healthcare services. The firm invests primarily in private companies but also have investments in public companies. For equity investments, the firm seeks to represent a controlling interest in its portfolio companies which may exceed 25% of the voting securities of such companies. The firm seeks to invest a limited portion of its assets in equipment-based loans to early-stage prospective portfolio companies. These loans are generally for amounts up to $3 million but may be up to $15 million for certain energy technology venture investments. The firm allows certain debt investments have the right to convert a portion of the debt investment into equity. It also co-invests with other private equity firms. The firm seeks to exit its investments through initial public offering, a private sale of equity interest to a third party, a merger or an acquisition of the company or a purchase of the equity position by the company or one of its stockholders. The firm has structured debt with warrants which typically have maturities of between two and seven years with an average of three years; senior debt with an investment horizon of less than three years; equipment loans with an investment horizon ranging from three to four years; and equity related securities with an investment horizon ranging from three to seven years. The firm prefers to invest through its balance sheet capital. The firm formerly known as Hercules Technology Growth Capital, Inc. Hercules Capital, Inc. was founded in December 2003 and is based in San Mateo, California with additional offices in North America and Europe.
Similar asset management company
Forbion is a European venture capital firm focused on life sciences, including biotechnology and medical technology. It manages investment funds and provides capital to innovative healthcare companies, primarily serving entrepreneurs and investors in the European life sciences sector.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of HBM Healthcare Investments AG and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for HBM Healthcare Investments AGand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →